Home » Topics » Disease categories and therapies » Immune

Immune
RSS

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Therapeutic Antibodies' CytoTAb enters clinical trials

Oct. 7, 1997

MOMP DNA immunization for chlamydial infections

Oct. 6, 1997

OraVax to market and distribute Evans Medical's yellow fever vaccine

Oct. 3, 1997

North American Vaccine advances with meningitis B vaccine

Oct. 2, 1997

Collaborators demonstrate protection against HSV with Cel-Sci vaccine

Oct. 1, 1997

LF-08-0299 both prevents and reverses kidney rejection in dogs

Sep. 30, 1997

FTY-720: novel immunosuppressant for combination therapy

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...